Cargando…
Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study
BACKGROUND: The efficacy of fixed-dose combinations (FDCs) in improving adherence and risk factor control for cardiovascular disease has not been reported consistently. Here, we compared adherence and efficacy between an olmesartan/rosuvastatin FDC and the usual regimen. METHODS: In this 6-month, op...
Autores principales: | Chung, Seyong, Ko, Young-Guk, Kim, Jung Sun, Kim, Byeong-Keuk, Ahn, Chul-Min, Park, Sungha, Hong, Sung-Jin, Lee, Sang-Hak, Choi, Donghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550343/ https://www.ncbi.nlm.nih.gov/pubmed/33346375 http://dx.doi.org/10.5603/CJ.a2020.0167 |
Ejemplares similares
-
Monotherapy versus combination therapy of statin and renin–angiotensin system inhibitor in ST-segment elevation myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2022) -
ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin–angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry
por: Kim, Yong Hoon, et al.
Publicado: (2022) -
Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
por: Kim, Yong Hoon, et al.
Publicado: (2023) -
Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry
por: Kim, Yong Hoon, et al.
Publicado: (2022) -
Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
por: Kim, Yong Hoon, et al.
Publicado: (2020)